GLENN JEFFREY S received a stock award from EIGER BIOPHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/11/2022ACC: 0001140361-22-009259
Director
Since Mar 2019
+18K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6K
Price / share
—
Trade value
—
% of position
7.9%
3/11/2022
76.36K→82.36K
Total
Net shares
+6K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2022 | A · Award | +6K | — | — | 7.9% | 76.36K | 82.36K |
| Total | +6K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12K shares
Shares
+12K
Strike price
5.1
Held after
12K
Exercisable
—
3/11/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12K shares | 3/11/2022 | A · Award | +12K | 5.1 | — | 12K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned5K
Common Stock
IndirectShares owned460.00
Common Stock
IndirectShares owned151.06K
Total
156.52K indirect156.52K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 5K | Indirect |
| Common Stock | 460.00 | Indirect |
| Common Stock | 151.06K | Indirect |
| Total | 156.52K | 156.52K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported